Jeong JH - Search Results

1

Spatial Distribution and Prognostic Implications of Tumor-Infiltrating FoxP3- CD4+ T Cells in Biliary Tract Cancer.

Kim HD, Kim JH, Ryu YM, Kim D, Lee S, Shin J, Hong SM, Kim KH, Jung DH, Song GW, Hwang DW, Lee JH, Song KB, Ryoo BY, Jeong JH, Kim KP, Kim SY, Yoo C. Kim HD, et al. Among authors: jeong jh. Cancer Res Treat. 2021 Jan;53(1):162-171. doi: 10.4143/crt.2020.704. Epub 2020 Aug 31. Cancer Res Treat. 2021. PMID: 32878426 Free PMC article.

2

Synthesis and hypoglycemic effect of chrysin derivatives.

Shin JS, Kim KS, Kim MB, Jeong JH, Kim BK. Shin JS, et al. Among authors: jeong jh. Bioorg Med Chem Lett. 1999 Mar 22;9(6):869-74. doi: 10.1016/s0960-894x(99)00092-x. Bioorg Med Chem Lett. 1999. PMID: 10206552

3

Safety and feasibility of adjuvant chemotherapy with S-1 for Korean patients with curatively resected advanced gastric cancer.

Jeong JH, Ryu MH, Ryoo BY, Lee SS, Park I, Lee SH, Kim KC, Yook JH, Oh ST, Kim BS, Kang YK. Jeong JH, et al. Cancer Chemother Pharmacol. 2012 Oct;70(4):523-9. doi: 10.1007/s00280-012-1935-6. Epub 2012 Aug 5. Cancer Chemother Pharmacol. 2012. PMID: 22864947

4

Associations between CYP2A6 polymorphisms and outcomes of adjuvant S-1 chemotherapy in patients with curatively resected gastric cancer.

Jeong JH, Park SR, Ahn Y, Ryu MH, Ryoo BY, Kong SY, Yook JH, Yoo MW, Kim BS, Kim BS, Kang YK. Jeong JH, et al. Gastric Cancer. 2017 Jan;20(1):146-155. doi: 10.1007/s10120-015-0586-9. Epub 2015 Dec 29. Gastric Cancer. 2017. PMID: 26715117

5

Phase 1 Study of Preoperative Chemoradiation Therapy With Temozolomide and Capecitabine in Patients With Locally Advanced Rectal Cancer.

Jeong JH, Hong YS, Park Y, Kim J, Kim JE, Kim KP, Kim SY, Park JH, Kim JH, Park IJ, Lim SB, Yu CS, Kim JC, Kim TW. Jeong JH, et al. Int J Radiat Oncol Biol Phys. 2016 Oct 1;96(2):289-295. doi: 10.1016/j.ijrobp.2016.05.009. Epub 2016 May 17. Int J Radiat Oncol Biol Phys. 2016. PMID: 27473815 Clinical Trial.

6

Association of nutritional status-related indices and chemotherapy-induced adverse events in gastric cancer patients.

Seo SH, Kim SE, Kang YK, Ryoo BY, Ryu MH, Jeong JH, Kang SS, Yang M, Lee JE, Sung MK. Seo SH, et al. Among authors: jeong jh. BMC Cancer. 2016 Nov 18;16(1):900. doi: 10.1186/s12885-016-2934-5. BMC Cancer. 2016. PMID: 27863481 Free PMC article.

7

HER2 Amplification and Cetuximab Efficacy in Patients With Metastatic Colorectal Cancer Harboring Wild-type RAS and BRAF.

Jeong JH, Kim J, Hong YS, Kim D, Kim JE, Kim SY, Kim KP, Yoon YK, Kim D, Chun SM, Park Y, Jang SJ, Kim TW. Jeong JH, et al. Clin Colorectal Cancer. 2017 Sep;16(3):e147-e152. doi: 10.1016/j.clcc.2017.01.005. Epub 2017 Jan 25. Clin Colorectal Cancer. 2017. PMID: 28223103

8

Prognostic Implication of Inflammation-based Prognostic Scores in Patients with Intrahepatic Cholangiocarcinoma Treated with First-line Gemcitabine plus Cisplatin.

Cho H, Yoo C, Kim KP, Jeong JH, Kang J, Chang HM, Lee SS, Park DH, Song TJ, Lee SK, Kim MH, Lee HC, Lim YS, Kim KM, Shim JH, Hwang S, Song GW, Moon DB, Lee JH, Lee YJ, Ryoo BY. Cho H, et al. Among authors: jeong jh. Invest New Drugs. 2018 Jun;36(3):496-502. doi: 10.1007/s10637-017-0548-7. Epub 2017 Dec 1. Invest New Drugs. 2018. PMID: 29192354

9

Multicenter Phase II Study of Oxaliplatin, Irinotecan, and S-1 as First-line Treatment for Patients with Recurrent or Metastatic Biliary Tract Cancer.

Yoo C, Han B, Kim HS, Kim KP, Kim D, Jeong JH, Lee JL, Kim TW, Kim JH, Choi DR, Ha HI, Seo J, Chang HM, Ryoo BY, Zang DY. Yoo C, et al. Among authors: jeong jh. Cancer Res Treat. 2018 Oct;50(4):1324-1330. doi: 10.4143/crt.2017.526. Epub 2018 Jan 8. Cancer Res Treat. 2018. PMID: 29334603 Free PMC article. Clinical Trial.

10

Nab-paclitaxel plus gemcitabine versus FOLFIRINOX as the first-line chemotherapy for patients with metastatic pancreatic cancer: retrospective analysis.

Kang J, Hwang I, Yoo C, Kim KP, Jeong JH, Chang HM, Lee SS, Park DH, Song TJ, Seo DW, Lee SK, Kim MH, Hong SM, Shin SH, Hwang DW, Song KB, Lee JH, Kim SC, Ryoo BY. Kang J, et al. Among authors: jeong jh. Invest New Drugs. 2018 Aug;36(4):732-741. doi: 10.1007/s10637-018-0598-5. Epub 2018 Apr 3. Invest New Drugs. 2018. PMID: 29616439

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,572 results

Search Page